Expands Lantronix’s IoT Wireless Connect Portfolio With Cutting-Edge 5G Technology Strengthens Competitive Offering, Adds New Blue-Chip Customers IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in IoT compute and connectivity IoT solutions, today announced that it has signed a definitive agreement to acquire from NetComm Wireless Pty Ltd (“NetComm”), a […]
Author: pr web
Bitget lance la cotation des jetons Swell (SWELL) sur Launchpool, Poolx et Spot avec 23 440 000 jetons en récompense
VICTORIA, Seychelles, 07 nov. 2024 (GLOBE NEWSWIRE) — Bitget, la principale bourse de crypto-monnaie et société Web3, a annoncé la cotation des jetons SWELL sur sa plateforme qui couvre une gamme de produits tels que Launchpool, Poolx et le trading Spot. Cette cotation permet aux utilisateurs éligibles de gagner des récompenses à partir d’un pool comprenant un […]
Bitget lance la cotation des jetons Swell (SWELL) sur Launchpool, Poolx et Spot avec 23 440 000 jetons en récompense
VICTORIA, Seychelles, 07 nov. 2024 (GLOBE NEWSWIRE) — Bitget, la principale bourse de crypto-monnaie et société Web3, a annoncé la cotation des jetons SWELL sur sa plateforme qui couvre une gamme de produits tels que Launchpool, Poolx et le trading Spot. Cette cotation permet aux utilisateurs éligibles de gagner des récompenses à partir d’un pool comprenant un […]
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences: Guggenheim’s Inaugural Healthcare Innovation Conference on November 12, […]
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences: Guggenheim’s Inaugural Healthcare Innovation Conference on November 12, […]